Literature DB >> 27498044

The Effect of Waiting Times for Postoperative Radiotherapy on Outcomes for Women Receiving Partial Mastectomy for Breast Cancer: a Systematic Review and Meta-Analysis.

S Gupta1, W D King2, M Korzeniowski3, D L Wallace4, W J Mackillop5.   

Abstract

AIMS: To determine the effect of delay in postoperative radiotherapy on local recurrence and overall survival in women receiving partial mastectomy for breast cancer.
MATERIALS AND METHODS: This was a systematic review and meta-analysis of published literature. Relevant reports were identified from MEDLINE, EMBASE and the Cochrane Register of Controlled Trials in all languages from 1975 to April 2015, in addition to the abstracts from the annual meetings of major radiotherapy conferences from 2000 to 2011. Reference lists were hand searched to find additional relevant reports and OvidSP's 'Find Citing' function was used to find studies citing papers identified in the primary search. Studies were included if they met the following criteria: (i) all patients received partial mastectomy and radiotherapy, (ii) a delay from surgery to radiotherapy was reported and (iii) one or more of local control/failure and/or survival were reported. Observational studies and randomised controlled trials were included. Studies including patients with in situ disease were excluded. Studies were classified as high quality if they adequately controlled for factors known to be associated with the outcomes of interest. Study quality was independently assessed by three authors. Initial disagreements about three studies were resolved by consensus. Only high-quality studies were included in the primary analysis. Delay was modelled as a continuous variable and the relative risk of local recurrence and the relative risk of death are reported per month of delay. The study results were combined using a fixed-effects model.
RESULTS: Thirty-four relevant publications including 79 616 patients were identified in the systematic review. Ten high-quality publications reported on local recurrence (13 291 patients) and four high-quality studies reported on overall survival (2207 patients). The relative risk of local recurrence per month of delay was 1.08 (95% confidence interval 1.02-1.14). The relative risk of death per month of delay was 0.99 (95% confidence interval 0.94-1.05).
CONCLUSIONS: Delays in post-lumpectomy radiotherapy are associated with a significant increase in the risk of local recurrence. We recommend that waiting times for radiotherapy should be kept as short as reasonably achievable.
Copyright © 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; radiotherapy; waiting times

Mesh:

Year:  2016        PMID: 27498044     DOI: 10.1016/j.clon.2016.07.010

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  14 in total

1.  The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview.

Authors:  Catherine Duggan; Allison Dvaladze; Anne F Rositch; Ophira Ginsburg; Cheng-Har Yip; Susan Horton; Rolando Camacho Rodriguez; Alexandru Eniu; Miriam Mutebi; Jean-Marc Bourque; Shahla Masood; Karla Unger-Saldaña; Anna Cabanes; Robert W Carlson; Julie R Gralow; Benjamin O Anderson
Journal:  Cancer       Date:  2020-05-15       Impact factor: 6.860

2.  Quality Of Breast Cancer Care In The US Territories: Insights From Medicare.

Authors:  Tracy M Layne; Jenerius A Aminawung; Pamela R Soulos; Marcella Nunez-Smith; Maxine A Nunez; Beth A Jones; Karen H Wang; Cary P Gross
Journal:  Health Aff (Millwood)       Date:  2018-03       Impact factor: 6.301

3.  The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women's Health Initiative.

Authors:  Rachel Yung; Roberta M Ray; Joshua Roth; Lisa Johnson; Greg Warnick; Garnet L Anderson; Candyce H Kroenke; Rowan T Chlebowski; Michael S Simon; Chunkit Fung; Kathy Pan; Di Wang; Wendy E Barrington; Kerryn W Reding
Journal:  Breast Cancer Res Treat       Date:  2020-02-15       Impact factor: 4.872

Review 4.  Evolution of radiotherapy techniques in breast conservation treatment.

Authors:  John Boyages; Lesley Baker
Journal:  Gland Surg       Date:  2018-12

5.  Association between waiting time for radiotherapy after surgery for early-stage breast cancer and survival outcomes in Ontario: a population-based outcomes study.

Authors:  M J Raphael; R Saskin; S Singh
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

6.  The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.

Authors:  Marissa C van Maaren; Reini W Bretveld; Jan J Jobsen; Renske K Veenstra; Catharina Gm Groothuis-Oudshoorn; Hendrik Struikmans; John H Maduro; Luc Ja Strobbe; Philip Mp Poortmans; Sabine Siesling
Journal:  Br J Cancer       Date:  2017-06-06       Impact factor: 7.640

7.  Impact of Delayed Adjuvant Radiotherapy in the Survival of Women with Breast Cancer.

Authors:  Christian H Flores-Balcázar; Lourdes Flores-Luna; Cynthia Villarreal-Garza; Aida Mota-García; Enrique Bargalló-Rocha
Journal:  Cureus       Date:  2018-07-30

8.  Early Rehabilitation after Total Mastectomy and Immediate Reconstruction with Tissue Expander Insertion in Breast Cancer Patients: A Retrospective Case-control Study.

Authors:  Kyou Hyun Kim; Seung Mi Yeo; In Yae Cheong; Yoon Kim; Byung Joon Jeon; Ji Hye Hwang
Journal:  J Breast Cancer       Date:  2019-09-05       Impact factor: 3.588

9.  The impact of waiting time on patient outcomes: Evidence from early intervention in psychosis services in England.

Authors:  Anika Reichert; Rowena Jacobs
Journal:  Health Econ       Date:  2018-07-16       Impact factor: 3.046

10.  Long-term survival effect of the interval between mastectomy and radiotherapy in locally advanced breast cancer.

Authors:  Wen-Wen Zhang; San-Gang Wu; Jia-Yuan Sun; Feng-Yan Li; Zhen-Yu He
Journal:  Cancer Manag Res       Date:  2018-07-16       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.